• Shlomo Cohen and Haim Shapiro.
• *Department of Philosophy, Diller Family Building, Ben-Gurion University, PO Box 653, Be'er-Sheva 84105, Israel. shlomco@mscc.huji.ac.il.
• J Med Philos. 2013 Dec 1; 38 (6): 696-709.

AbstractRecent research, especially with functional brain imaging, demonstrated cases where the administration of a placebo produces objective effects in tissues that are indistinguishable from those of the real therapeutic agents. This phenomenon has been shown in treatments of pain, depression, Parkinsonism, and more. The main ethical complaint against placebo treatment is that it is a kind of deception, where supposedly we substitute what works just psychologically for a real drug that actually works on the tissue level. We claim that the scientific findings bring to a new level the seeming deconstruction of the distinction between "placebo" and "real" drugs, and that instances of placebo treatment which fulfill this criterion should be recognized as a unique category-we call it "comparable placebo treatment" (CPT). The paper uses an analysis of the notion of deception to argue that CPT does not amount to deception; that it can preserve patient autonomy; and that it is therefore morally legitimate.

20 keywords...

hide…